Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Walmart Inc.

Strategists at JPMorgan say retail investors will help drive stock gains this year, and foreign investors could pitch in.

That cohort is going to keep driving the market higher, says our call of the day from JPMorgan, which predicts that retail investors will lead a $500 billion wall of money flowing into U.S. stocks in ...

Cathie Wood, chief of Ark Investment Management, sold $47.9 million of a crypto stock over the past week after it surged 37% ...

Investors in U.S. stock markets need to stop obsessing about when, and by how much, the Federal Reserve will cut interest ...

Silicon Valley chipmaker Nvidia on Wednesday became the first publicly traded company to surpass a $4 trillion market ...

Pershing Square Capital Management's billionaire chief has sold most of his fund's stake in Chipotle over seven years, and is ...

Tidal Financial Group and AOT Invest proudly announce the launch of the 2x Daily Software Platform ETF (NYSE: SOFL), an innovative new fund designed for traders seeking magnified exposure to the ...

We quantify the role of global production linkages in explaining spillovers of U.S. monetary policy shocks to stock returns across countries and sectors using a newly constructed dataset. Our ...